Prevalence of Multidrug-Resistance and Extensively-drug Resistance in Gram-Negative Clinical Isolates from Outpatients

被引:0
作者
Fatima, Sakina [1 ]
Muhammad, Iyad N. [1 ]
Usman, Shahnaz [2 ]
Jamil, Subia [3 ]
机构
[1] Univ Karachi, Fac Pharm & Pharmaceut Sci, Dept Pharmaceut, Karachi, Pakistan
[2] RAK Med & Hlth Sci Univ, RAK Coll Pharmaceut Sci, Dept Pharmaceut, Ras Al Khaymah, U Arab Emirates
[3] Jinnah Univ Women, Fac Pharm, Karachi, Pakistan
来源
LATIN AMERICAN JOURNAL OF PHARMACY | 2017年 / 36卷 / 06期
关键词
antimicrobial susceptibility; gram-negative bacteria; multidrug-resistance; possible extensively-drug resistance; SPECTRUM BETA-LACTAMASES; PSEUDOMONAS-AERUGINOSA; KLEBSIELLA-PNEUMONIAE; ESCHERICHIA-COLI; RISK-FACTORS; INFECTIONS; FOSFOMYCIN; BACTEREMIA;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of the study was to identify multidrug-resistance (MDR) and extensively drug-resistance (XDR) in clinical isolates of gram-negative bacteria obtained from specimens of non-hospitalized patients. A cross-sectional study was conducted over a period of one year (January 2015 to December 2015) and samples were cultured and bacterial strains were identified. Susceptibility of bacteria against different antibiotics was analyzed to identify MDR and XDR. A total of 1005 of Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa and Proteus mirabilis isolates were analyzed by the disc diffusion method. MDR was found in 91% (620/680), 56% (140/248), 62.16% (46/74) and 0%, whereas XDR was found 6.32% (43/680), 12.6% (31/248), 37.83% (28/74) and 0% respectively. It was concluded that a high prevalence of MDR was found in gram-negative isolates along with appearance of possible XDR. So it is needed to monitor the appropriate use of antibiotics and to perform proper screenings along with hygienic practices to overcome the risk of infections.
引用
收藏
页码:1164 / 1168
页数:5
相关论文
共 34 条
[1]   Molecular mechanisms of antibacterial multidrug resistance [J].
Alekshun, Michael N. ;
Levy, Stuart B. .
CELL, 2007, 128 (06) :1037-1050
[2]  
[Anonymous], M100S24 CLIN LAB STA
[3]  
Arsalan A, 2014, PAK J PHARM SCI, V27, P97
[4]  
Basak S., 2015, J PATHOL, V2016, P5
[6]   High Prevalence of Multidrug-Resistant Nonfermenters in Hospital-acquired Pneumonia in Asia [J].
Chung, Doo Ryeon ;
Song, Jae-Hoon ;
Kim, So Hyun ;
Thamlikitkul, Visanu ;
Huang, Shao-Guang ;
Wang, Hui ;
So, Thomas Man-kit ;
Yasin, Rohani M. D. ;
Hsueh, Po-Ren ;
Carlos, Celia C. ;
Hsu, Li Yang ;
Buntaran, Latre ;
Lalitha, M. K. ;
Kim, Min Ja ;
Choi, Jun Yong ;
Kim, Sang Il ;
Ko, Kwan Soo ;
Kang, Cheol-In ;
Peck, Kyong Ran .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 184 (12) :1409-1417
[7]   Resistance surveillance studies: a multifaceted problem-the fluoroquinolone example [J].
Dalhoff, A. .
INFECTION, 2012, 40 (03) :239-262
[8]   Proteus mirabilis bloodstream infections:: Risk factors and treatment outcome related to the expression of extended-spectrum β-lactamases [J].
Endimiani, A ;
Luzzaro, F ;
Brigante, G ;
Perilli, M ;
Lombardi, G ;
Amicosante, G ;
Rossolini, GM ;
Toniolo, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (07) :2598-2605
[9]   Antimicrobial susceptibility of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Enterobacteriaceae isolates to fosfomycin [J].
Falagas, Matthew E. ;
Maraki, Sofia ;
Karageorgopoulos, Drosos E. ;
Kastoris, Antonia C. ;
Mavromanolakis, Emmanuel ;
Samonis, George .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2010, 35 (03) :240-243
[10]   Other antimicrobials of interest in the era of extended-spectrum β-lactamases:: fosfomycin, nitrofurantoin and tigecycline [J].
Garau, J. .
CLINICAL MICROBIOLOGY AND INFECTION, 2008, 14 :198-202